Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Strategies for Balloon-Uncrossable Chronic Total Occlusion Lesions.

Strauss BH, Elbaz-Greener G.

Cardiovasc Revasc Med. 2018 Oct - Nov;19(7 Pt B):816-817. doi: 10.1016/j.carrev.2018.10.027. No abstract available.

PMID:
30522782
2.

Long-term impact of chronic total occlusion recanalisation in patients with ST-elevation myocardial infarction.

Elias J, van Dongen IM, Råmunddal T, Laanmets P, Eriksen E, Meuwissen M, Michels HR, Bax M, Ioanes D, Suttorp MJ, Strauss BH, Barbato E, Marques KM, Claessen BEPM, Hirsch A, van der Schaaf RJ, Tijssen JGP, Henriques JPS, Hoebers LP; EXPLORE investigators.

Heart. 2018 Sep;104(17):1432-1438. doi: 10.1136/heartjnl-2017-312698. Epub 2018 Feb 20.

PMID:
29463612
3.

Coronary intervention for chronic total occlusions: what should the guidelines say?

Elbaz-Greener G, Strauss BH.

Coron Artery Dis. 2018 Jun;29(4):279-282. doi: 10.1097/MCA.0000000000000606. No abstract available.

PMID:
29351093
4.

Biomarker Screening for Viable Myocardium in Ischemic Cardiomyopathy: Interesting… If Viability Is Important.

Strauss BH, Roifman I.

Can J Cardiol. 2017 Nov;33(11):1457-1458. doi: 10.1016/j.cjca.2017.08.007. Epub 2017 Aug 19. No abstract available.

PMID:
28966020
5.

Management of Chronic Total Coronary Occlusion in Stable Ischemic Heart Disease by Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Versus Medical Therapy.

Shuvy M, Qiu F, Chee-A-Tow A, Graham JJ, Abuzeid W, Buller C, Strauss BH, Wijeysundera HC.

Am J Cardiol. 2017 Sep 1;120(5):759-764. doi: 10.1016/j.amjcard.2017.05.061. Epub 2017 Jun 15.

PMID:
28716335
6.

Hemorrhage promotes inflammation and myocardial damage following acute myocardial infarction: insights from a novel preclinical model and cardiovascular magnetic resonance.

Ghugre NR, Pop M, Thomas R, Newbigging S, Qi X, Barry J, Strauss BH, Wright GA.

J Cardiovasc Magn Reson. 2017 Jul 4;19(1):50. doi: 10.1186/s12968-017-0361-7.

7.

Inflammatory Markers and Brain-Derived Neurotrophic Factor as Potential Bridges Linking Bipolar Disorder and Cardiovascular Risk Among Adolescents.

Hatch JK, Scola G, Olowoyeye O, Collins JE, Andreazza AC, Moody A, Levitt AJ, Strauss BH, Lanctot KL, Goldstein BI.

J Clin Psychiatry. 2017 Mar;78(3):e286-e293. doi: 10.4088/JCP.16m10762.

PMID:
28199074
8.

Clinical outcomes after trans-catheter aortic valve replacement in men and women in Ontario, Canada.

Czarnecki A, Qiu F, Koh M, Prasad TJ, Cantor WJ, Cheema AN, Chu MWA, Feindel C, Fremes SE, Kingsbury K, Natarajan MK, Peterson MD, Ruel M, Strauss BH, Wijeysundera HC, Ko DT.

Catheter Cardiovasc Interv. 2017 Sep 1;90(3):486-494. doi: 10.1002/ccd.26906. Epub 2017 Feb 1.

PMID:
28145088
9.

CoreValve Prosthesis Depth: What is the Optimal Measurement Target?

Wolff R, Radhakrishnan S, Mitsuhashi H, Zavodni A, Roifman I, Sparkes JD, Fremes SE, Bakar-Irwin S, Hansen MS, Strauss BH.

J Heart Valve Dis. 2016 Jul;25(4):417-423.

PMID:
28009943
10.

Long-term Follow-up of Coronary Artery Bypass Patients With Preoperative and New Postoperative Native Coronary Artery Chronic Total Occlusion.

Pereg D, Fefer P, Samuel M, Shuvy M, Deb S, Sparkes JD, Fremes SE, Strauss BH.

Can J Cardiol. 2016 Nov;32(11):1326-1331. doi: 10.1016/j.cjca.2016.01.015. Epub 2016 Jan 22.

PMID:
27118056
11.

Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With STEMI: The EXPLORE Trial.

Henriques JP, Hoebers LP, Råmunddal T, Laanmets P, Eriksen E, Bax M, Ioanes D, Suttorp MJ, Strauss BH, Barbato E, Nijveldt R, van Rossum AC, Marques KM, Elias J, van Dongen IM, Claessen BE, Tijssen JG, van der Schaaf RJ; EXPLORE Trial Investigators.

J Am Coll Cardiol. 2016 Oct 11;68(15):1622-1632. doi: 10.1016/j.jacc.2016.07.744.

12.

Percutaneous Coronary Intervention in a Patient With Severe Systemic Vasculitis and Myocardial Infarction.

Ward MR, Abuzeid W, Venus K, Kyryllo D, Radhakrishnan S, Strauss BH, Bell M, Ahmed S.

Can J Cardiol. 2016 Dec;32(12):1574.e11-1574.e13. doi: 10.1016/j.cjca.2016.01.011. Epub 2016 Jan 21.

PMID:
26971240
13.

Acute and long-term effect of percutaneous coronary intervention on serially-measured oxidative, inflammatory, and coagulation biomarkers in patients with stable angina.

Leibundgut G, Lee JH, Strauss BH, Segev A, Tsimikas S.

J Thromb Thrombolysis. 2016 May;41(4):569-80. doi: 10.1007/s11239-016-1351-6.

14.

Reply to Boyd et al.: Large long-term sea level projections do not mean giving up on coastal cities.

Strauss BH, Kulp S, Levermann A.

Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):E1330. doi: 10.1073/pnas.1601065113. Epub 2016 Feb 24. No abstract available.

15.

Distal coronary embolization following acute myocardial infarction increases early infarct size and late left ventricular wall thinning in a porcine model.

Thomas RM, Lim SY, Qiang B, Osherov AB, Ghugre NR, Noyan H, Qi X, Wolff R, Ladouceur-Wodzak M, Berk TA, Butany J, Husain M, Wright GA, Strauss BH.

J Cardiovasc Magn Reson. 2015 Dec 1;17:106. doi: 10.1186/s12968-015-0197-y.

16.

Gender differences in the prevalence and treatment of coronary chronic total occlusions.

Wolff R, Fefer P, Knudtson ML, Cheema AN, Galbraith PD, Sparkes JD, Wright GA, Wijeysundera HC, Strauss BH.

Catheter Cardiovasc Interv. 2016 May;87(6):1063-70. doi: 10.1002/ccd.26330. Epub 2015 Nov 25.

PMID:
26602868
17.

Carbon choices determine US cities committed to futures below sea level.

Strauss BH, Kulp S, Levermann A.

Proc Natl Acad Sci U S A. 2015 Nov 3;112(44):13508-13. doi: 10.1073/pnas.1511186112. Epub 2015 Oct 12.

18.

suPAR: A Cardiac Biomarker With a Future?

Arbel Y, Strauss BH.

Can J Cardiol. 2015 Oct;31(10):1223-4. doi: 10.1016/j.cjca.2015.08.011. Epub 2015 Aug 20. No abstract available.

PMID:
26429353
19.

Mortality benefits with CTO PCI: moving the goalpost closer.

Arbel Y, Strauss BH.

Eur Heart J. 2015 Dec 1;36(45):3199-201. doi: 10.1093/eurheartj/ehv432. Epub 2015 Sep 2. No abstract available.

PMID:
26333368
20.

Appropriateness of percutaneous revascularization of coronary chronic total occlusions: an overview.

Galassi AR, Brilakis ES, Boukhris M, Tomasello SD, Sianos G, Karmpaliotis D, Di Mario C, Strauss BH, Rinfret S, Yamane M, Katoh O, Werner GS, Reifart N.

Eur Heart J. 2016 Sep 14;37(35):2692-700. doi: 10.1093/eurheartj/ehv391. Epub 2015 Aug 7. Review.

PMID:
26254179
21.

Complex percutaneous interventions: what is the role for specialized bifurcation stents?

Shuvy M, Strauss BH.

Can J Cardiol. 2015 May;31(5):588-90. doi: 10.1016/j.cjca.2015.01.026. Epub 2015 Jan 28. No abstract available.

PMID:
25936486
22.

MitraClip for papillary muscle rupture in patient with cardiogenic shock.

Wolff R, Cohen G, Peterson C, Wong S, Hockman E, Lo J, Strauss BH, Cohen EA.

Can J Cardiol. 2014 Nov;30(11):1461.e13-4. doi: 10.1016/j.cjca.2014.07.015. Epub 2014 Jul 22.

PMID:
25442448
23.

The mini-STAR technique in chronic total occlusions: maximizing the interventional toolbox.

Shuvy M, Strauss BH.

Can J Cardiol. 2014 Nov;30(11):1253-5. doi: 10.1016/j.cjca.2014.09.004. Epub 2014 Sep 15. No abstract available.

PMID:
25442427
24.

Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia.

Qiang B, Lim SY, Lekas M, Kuliszewski MA, Wolff R, Osherov AB, Rudenko D, Leong-Poi H, Noyan H, Husain M, Tran K, Tryggvason K, Hedin U, Tran-Lundmark K, Strauss BH.

Can J Cardiol. 2014 Nov;30(11):1444-51. doi: 10.1016/j.cjca.2014.06.003. Epub 2014 Jun 12.

PMID:
25249499
25.

Revascularization of chronic total occlusions: time to reconsider?

Strauss BH, Shuvy M, Wijeysundera HC.

J Am Coll Cardiol. 2014 Sep 23;64(12):1281-9. doi: 10.1016/j.jacc.2014.06.1181. Review.

26.

Team science for science communication.

Wong-Parodi G, Strauss BH.

Proc Natl Acad Sci U S A. 2014 Sep 16;111 Suppl 4:13658-63. doi: 10.1073/pnas.1320021111. Epub 2014 Sep 15.

27.

Comparison of the efficacy of pharmacoinvasive management for ST-segment elevation myocardial infarction in smokers versus non-smokers (from the Trial of Routine Angioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction).

Tan NS, Goodman SG, Cantor WJ, Tan MK, Yan RT, Bagnall AJ, Mehta SR, Fitchett D, Strauss BH, Yan AT; TRANSFER-AMI Investigators.

Am J Cardiol. 2014 Oct 1;114(7):955-61. doi: 10.1016/j.amjcard.2014.05.069. Epub 2014 Jul 16.

PMID:
25118119
28.

Native coronary artery patency after coronary artery bypass surgery.

Pereg D, Fefer P, Samuel M, Wolff R, Czarnecki A, Deb S, Sparkes JD, Fremes SE, Strauss BH.

JACC Cardiovasc Interv. 2014 Jul;7(7):761-7. doi: 10.1016/j.jcin.2014.01.164.

29.

Unexpected calcification after direct intravascular injection of autologous bone marrow-derived cells in a chronic total occlusion model.

Nili N, Lim SY, Qiang B, Qi X, Weisbrod MJ, Ladouceur-Wodzak M, Gofine N, Berk TA, Saperia J, Wright GA, Strauss BH.

EuroIntervention. 2014 Jul;10(3):329-36. doi: 10.4244/EIJV10I3A56.

30.

Stent thrombosis following drug-eluting stents in STEMI: "Much ado about nothing?".

Strauss BH, Shuvy M.

J Am Coll Cardiol. 2014 Jul 8;64(1):25-7. doi: 10.1016/j.jacc.2014.04.026. No abstract available.

31.

Heparan sulfate side chains have a critical role in the inhibitory effects of perlecan on vascular smooth muscle cell response to arterial injury.

Gotha L, Lim SY, Osherov AB, Wolff R, Qiang B, Erlich I, Nili N, Pillarisetti S, Chang YT, Tran PK, Tryggvason K, Hedin U, Tran-Lundmark K, Advani SL, Gilbert RE, Strauss BH.

Am J Physiol Heart Circ Physiol. 2014 Aug 1;307(3):H337-45. doi: 10.1152/ajpheart.00654.2013. Epub 2014 May 23.

32.

Relationship between initial treatment strategy and quality of life in patients with coronary chronic total occlusions.

Wijeysundera HC, Norris C, Fefer P, Galbraith PD, Knudtson ML, Wolff R, Wright GA, Strauss BH, Ko DT.

EuroIntervention. 2014 Feb;9(10):1165-72. doi: 10.4244/EIJV9I10A197.

33.

Comparison of the frequencies of myocardial edema determined by cardiac magnetic resonance in diabetic versus nondiabetic patients having percutaneous coronary intervention for ST elevation myocardial infarction.

Zia MI, Ghugre NR, Roifman I, Strauss BH, Walcarius R, Mohammed M, Sparkes JD, Dick AJ, Wright GA, Connelly KA.

Am J Cardiol. 2014 Feb 15;113(4):607-12. doi: 10.1016/j.amjcard.2013.10.040. Epub 2013 Nov 22.

PMID:
24332697
34.

A novel lead attenuator to reduce operator exposure to scattered radiation in transradial coronary procedures.

Osherov AB, Seidelin P, Wolff R, Wright GA, Strauss BH, Robert N.

EuroIntervention. 2013 Oct;9(6):757-60. doi: 10.4244/EIJV9I6A121. No abstract available.

35.

The effect of percutaneous coronary intervention of chronically totally occluded coronary arteries on left ventricular global and regional systolic function.

Roifman I, Paul GA, Zia MI, Williams LK, Watkins S, Wijeysundera HC, Crean AM, Strauss BH, Dick AJ, Wright GA, Connelly KA.

Can J Cardiol. 2013 Nov;29(11):1436-42. doi: 10.1016/j.cjca.2013.06.007. Epub 2013 Sep 6.

PMID:
24011798
36.

The use of ultrasound-stimulated contrast agents as an adjuvant for collagenase therapy in chronic total occlusions.

Thind AS, Strauss BH, Karshafian R, Teitelbaum AA, Ladouceur M, Akbar MA, Rosen B, Bohnen M, Whyne CM, Goertz DE, Foster FS.

EuroIntervention. 2014 Aug;10(4):484-93. doi: 10.4244/EIJV10I4A82.

37.

In vivo feasibility study of ultrasound potentiated collagenase therapy of chronic total occlusions.

Goertz DE, Thind AS, Karshafian R, Ladouceur M, Whyne CM, Foster FS, Strauss BH.

Ultrasonics. 2014 Jan;54(1):20-4. doi: 10.1016/j.ultras.2013.07.014. Epub 2013 Jul 29.

PMID:
23948508
38.

Rapid accumulation of committed sea-level rise from global warming.

Strauss BH.

Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13699-700. doi: 10.1073/pnas.1312464110. Epub 2013 Jul 29. No abstract available.

39.

Diabetic patients receiving bare-metal stents: no option patients?

Strauss BH.

J Am Coll Cardiol. 2013 Apr 23;61(16):1686-7. doi: 10.1016/j.jacc.2013.01.056. Epub 2013 Apr 2. No abstract available.

40.

Angiographic and clinical outcomes after implantation of drug eluting stents in bifurcation lesions with crush or kissing stent technique.

Cheema AN, Jolly SS, Burstein JM, Sharieff W, Mohammad A, Yeoh E, Mancini GB, Cantor WJ, Kutryk MJ, Strauss BH, Chisholm RJ.

J Interv Cardiol. 2013 Apr;26(2):145-52. doi: 10.1111/j.1540-8183.2013.12022.x. Epub 2013 Feb 13.

PMID:
23406435
41.

Therapeutic angiogenesis with VEGF164 for facilitation of guidewire crossing in experimental arterial chronic total occlusions.

Teitelbaum AA, Qi X, Osherov AB, Fraser AR, Ladouceur-Wodzak M, Munce N, Qiang B, Weisbrod M, Bierstone D, Erlich I, Sparkes JD, Wright GA, Strauss BH.

EuroIntervention. 2013 Jan 22;8(9):1081-9. doi: 10.4244/EIJV8I9A165.

42.

Characterizing myocardial edema and hemorrhage using quantitative T2 and T2* mapping at multiple time intervals post ST-segment elevation myocardial infarction.

Zia MI, Ghugre NR, Connelly KA, Strauss BH, Sparkes JD, Dick AJ, Wright GA.

Circ Cardiovasc Imaging. 2012 Sep 1;5(5):566-72. Epub 2012 Jun 28.

PMID:
22744938
43.

Hybrid intravascular ultrasound and optical coherence tomography catheter for imaging of coronary atherosclerosis.

Li BH, Leung AS, Soong A, Munding CE, Lee H, Thind AS, Munce NR, Wright GA, Rowsell CH, Yang VX, Strauss BH, Foster FS, Courtney BK.

Catheter Cardiovasc Interv. 2013 Feb;81(3):494-507. doi: 10.1002/ccd.24295. Epub 2012 May 4.

PMID:
22566368
44.

Characterisation of a novel porcine coronary artery CTO model.

Fefer P, Robert N, Qiang B, Liu G, Munce N, Anderson K, Osherov AB, Ladouceur-Wodzak M, Qi X, Dick A, Weisbrod M, Samuel M, Butany J, Wright G, Strauss BH.

EuroIntervention. 2012 Apr;7(12):1444-52. doi: 10.4244/EIJV7I12A225.

45.

Statin therapy prevents expansive remodeling in venous bypass grafts.

Qiang B, Toma J, Fujii H, Osherov AB, Nili N, Sparkes JD, Fefer P, Samuel M, Butany J, Leong-Poi H, Strauss BH.

Atherosclerosis. 2012 Jul;223(1):106-13. doi: 10.1016/j.atherosclerosis.2012.03.013. Epub 2012 Mar 22.

PMID:
22503825
46.

Thrombus aspiration during primary percutaneous coronary intervention is associated with reduced myocardial edema, hemorrhage, microvascular obstruction and left ventricular remodeling.

Zia MI, Ghugre NR, Connelly KA, Joshi SB, Strauss BH, Cohen EA, Wright GA, Dick AJ.

J Cardiovasc Magn Reson. 2012 Mar 26;14:19. doi: 10.1186/1532-429X-14-19.

47.

Current perspectives on coronary chronic total occlusions: the Canadian Multicenter Chronic Total Occlusions Registry.

Fefer P, Knudtson ML, Cheema AN, Galbraith PD, Osherov AB, Yalonetsky S, Gannot S, Samuel M, Weisbrod M, Bierstone D, Sparkes JD, Wright GA, Strauss BH.

J Am Coll Cardiol. 2012 Mar 13;59(11):991-7. doi: 10.1016/j.jacc.2011.12.007.

48.

Randomized trial of insulin versus usual care in reducing restenosis after coronary intervention in patients with diabetes. the STent Restenosis And Metabolism (STREAM) study.

Natarajan MK, Strauss BH, Rokoss M, Buller CE, Mancini GB, Xie C, Sheth TN, Goodhart D, Cohen EA, Seidelin P, Harper W, Gerstein HC.

Cardiovasc Revasc Med. 2012 Mar-Apr;13(2):95-100. doi: 10.1016/j.carrev.2011.12.001. Epub 2012 Jan 30.

PMID:
22296781
49.

Collagenase Total Occlusion-1 (CTO-1) trial: a phase I, dose-escalation, safety study.

Strauss BH, Osherov AB, Radhakrishnan S, Mancini GB, Manners A, Sparkes JD, Chisholm RJ.

Circulation. 2012 Jan 24;125(3):522-8. doi: 10.1161/CIRCULATIONAHA.111.063198. Epub 2011 Dec 16.

50.

The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization.

Fefer P, Tsimikas S, Segev A, Sparkes J, Otsuka F, Kolodgie F, Virmani R, Juliano J, Charron T, Strauss BH.

Cardiovasc Revasc Med. 2012 Jan-Feb;13(1):11-9. doi: 10.1016/j.carrev.2011.08.001. Epub 2011 Nov 13. Erratum in: Cardiovasc Revasc Med. 2014 Mar;15(2):127. Otsuma, Fumiyuki [corrected to Otsuka, Fumiyuki].

PMID:
22079685

Supplemental Content

Loading ...
Support Center